A detailed history of Steel Peak Wealth Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Steel Peak Wealth Management LLC holds 3,111 shares of BMY stock, worth $125,839. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,111
Holding current value
$125,839
% of portfolio
0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

BUY
$47.98 - $54.4 $149,265 - $169,238
3,111 New
3,111 $168,000
Q2 2023

Aug 02, 2023

BUY
$63.71 - $70.74 $97,157 - $107,878
1,525 Added 12.32%
13,900 $888,000
Q1 2023

May 05, 2023

BUY
$65.71 - $74.53 $180,571 - $204,808
2,748 Added 28.54%
12,375 $857,000
Q4 2022

Jan 25, 2023

BUY
$68.48 - $81.09 $19,859 - $23,516
290 Added 3.11%
9,627 $0
Q3 2022

Oct 26, 2022

SELL
$0.13 - $76.84 $334 - $197,939
-2,576 Reduced 21.62%
9,337 $664,000
Q2 2022

Aug 02, 2022

BUY
$72.62 - $79.98 $286,631 - $315,681
3,947 Added 49.55%
11,913 $924,000
Q1 2022

May 10, 2022

BUY
$61.48 - $73.72 $489,749 - $587,253
7,966 New
7,966 $582,000
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $799,010 - $870,122
-12,906 Closed
0 $0
Q1 2021

May 18, 2021

BUY
$59.34 - $66.74 $765,842 - $861,346
12,906 New
12,906 $815,000
Q3 2020

Oct 26, 2020

SELL
$57.43 - $63.64 $473,567 - $524,775
-8,246 Closed
0 $0
Q2 2020

Jul 21, 2020

BUY
$54.82 - $64.09 $58,876 - $68,832
1,074 Added 14.97%
8,246 $485,000
Q1 2020

Apr 16, 2020

SELL
$46.4 - $67.43 $1.31 Million - $1.91 Million
-28,304 Reduced 79.78%
7,172 $400,000
Q4 2019

Feb 06, 2020

BUY
$49.21 - $64.19 $1.75 Million - $2.28 Million
35,476 New
35,476 $2.28 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $86B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Steel Peak Wealth Management LLC Portfolio

Follow Steel Peak Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steel Peak Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steel Peak Wealth Management LLC with notifications on news.